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The C. elegans insulin/IGF-1 signaling (IIS) cascade
plays a central role in regulating life span, dauer,
metabolism, and stress. Themajor regulatory control
of IIS is through phosphorylation of its components
by serine/threonine-specific protein kinases. An
RNAi screen for serine/threonine protein phospha-
tases that counterbalance the effect of the kinases
in the IIS pathway identified pptr-1, a B56 regulatory
subunit of the PP2A holoenzyme. Modulation of
pptr-1 affects IIS pathway-associated phenotypes
including life span, dauer, stress resistance, and fat
storage. We show that PPTR-1 functions by regu-
lating worm AKT-1 phosphorylation at Thr 350. With
striking conservation, mammalian B56b regulates
Akt phosphorylation at Thr 308 in 3T3-L1 adipocytes.
In C. elegans, this ultimately leads to changes in
subcellular localization and transcriptional activity
of the forkhead transcription factor DAF-16. This
study reveals a conserved role for the B56 regulatory
subunit in regulating insulin signaling through AKT
dephosphorylation, thereby having widespread
implications in cancer and diabetes research.
INTRODUCTION
The insulin/IGF-1-like signaling (IIS) pathway is an evolutionarily
conserved neuroendocrine pathway that regulates metabolism,
development, stress resistance, and life span (Antebi, 2007;
Barbieri et al., 2003; Kenyon, 2005; Wolff and Dillin, 2006). In
Caenorhabditis elegans (C. elegans), the insulin-like receptor
DAF-2 (Kimura et al., 1997) signals through a PI 3-kinase (AGE-1/
AAP-1) (Morris et al., 1996; Wolkow et al., 2002) signaling
cascade that activates the downstream serine/threonine kinases
PDK-1, AKT-1, AKT-2, and SGK-1 (Hertweck et al., 2004; Para-
dis et al., 1999; Paradis and Ruvkun, 1998). These kinases in turnfunction to negatively regulate the forkhead transcription factor
(FOXO), DAF-16 (Lin et al., 1997; Ogg et al., 1997).
Reduction-of-function mutations in serine/threonine kinases
upstream of DAF-16 lead to changes in life span, development,
metabolism, and/or stress resistance (Antebi, 2007; Kenyon,
2005; Wolff and Dillin, 2006). Importantly, loss-of-function muta-
tions in daf-16 completely suppress these phenotypes (Antebi,
2007; Kenyon, 2005; Mukhopadhyay et al., 2006; Wolff and
Dillin, 2006). Thus, DAF-16 is a major downstream target of the
IIS pathway. Regulation of DAF-16 by AKT-1, AKT-2, and
SGK-1 results in its nuclear exclusion and sequestration in the
cytosol (Lin et al., 2001) (Hertweck et al., 2004; Lee et al.,
2001). In contrast, under low signaling conditions, active DAF-16
enters the nucleus and transactivates or represses its direct
target genes (Henderson and Johnson, 2001; Hertweck et al.,
2004; Lee et al., 2001; Lin et al., 2001; Oh et al., 2006). Strikingly,
this negative regulation of FOXO/DAF-16 is conserved across
species. In mammals, the AKT and SGK kinases can phosphory-
late and negatively regulate FOXO (Brunet et al., 1999; Brunet
et al., 2001).
Although regulation of the IIS pathway by serine/threonine
protein kinases has been extensively studied, little is known
about the phosphatases acting in this pathway. In C. elegans,
the lipid phosphatase DAF-18 (homologous to mammalian
Phosphatase and Tensin Homolog, PTEN) is the only phospha-
tase that has been identified and characterized as a negative
regulator of the IIS pathway (Gil et al., 1999; Mihaylova et al.,
1999; Ogg and Ruvkun, 1998; Rouault et al., 1999). The
increased life span of daf-2 mutant worms is suppressed by
loss-of-function mutation in daf-18 (Dorman et al., 1995; Larsen
et al., 1995). Therefore, to identify additional regulators of the IIS
pathway, we performed a directed RNAi screen of serine/threo-
nine protein phosphatases that affect phenotypes regulated by
the IIS pathway.
C. elegans development proceeds from an egg, through four
larval stages into a self-fertilizing, hermaphrodite adult.
However, under unfavorable growth conditions such as crowd-
ing and low food availability, worms enter a stage of diapause
known as dauer (Riddle et al., 1997). Upon favorable growthCell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc. 939
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Figure 1. pptr-1, a Regulatory Subunit of the PP2A Holoenzyme, Was Identified as a Top Candidate in a Directed RNAi Screen to Identify
Serine/Threonine Phosphatases that Regulate the IIS Pathway
(A) The different families and classes of the phosphatases included in the RNAi screen.
(B) A schematic representation of the RNAi screen. All the assays were performed in triplicate.
(C) The top two candidates that dramatically suppressed daf-2(e1370) dauer formation at 20C (fem-2, and pptr-1). Both fem-2 and pptr-1 RNAi were able to
suppress daf-2 dauer formation to a similar level as daf-18 RNAi. Error bars indicate the standard deviations among the different RNAi plates within one
experiment. Data shown [% Dauers ± Std. Dev. (n)] are from one representative experiment.
(D) pptr-1 is the only PP2A regulatory subunit family member that dramatically suppresses daf-2(1370) dauer formation. Error bars indicate the standard
deviations among the different RNAi plates within one experiment. Data shown are from one representative experiment.conditions, dauers are able to form reproductive adults. Since
worms form dauers constitutively when the function of IIS
pathway is reduced by mutations, we took advantage of
a temperature-sensitive (ts) allele of daf-2 for the RNAi screen
(Riddle et al., 1981). We screened for genes that suppressed
dauer formation indaf-2(e1370)mutants. In this report, we chara-
cterize PPTR-1, a regulatory subunit of the PP2A holoenzyme,
as an important regulator of development, longevity, metabo-
lism, and stress response in C. elegans. We show that PPTR-1
acts by modulating AKT-1 phosphorylation and as a conse-
quence controls DAF-16 activity.
RESULTS
RNAi Screen to Identify Phosphatases in the IIS Pathway
To identify the serine/threonine phosphatases in the C. elegans
genome, we performed in silico analyses using both NCBI
KOGs (clusters of euKaryotic Orthologous Groups) and Worm-
Base (a C. elegans database: http://www.wormbase.org; WS152)
annotations. A total of 60 genes were identified for further940 Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc.analysis (Figure 1A). We obtained RNAi clones for these phos-
phatases from the Ahringer RNAi library (Kamath et al., 2003),
generated themusing available clones from theORFeome library
(Reboul et al., 2003), or cloned them de novo using Gateway
Technology (Invitrogen, USA; Experimental Procedures). We
were unable to clone three of the phosphatase cDNAs and
therefore screened a total of 57 candidates.
In addition, we included six of the seven annotated PP2A holo-
enzyme regulatory subunits (one was not cloned) in the screen
for two reasons. First, a preliminary chemical inhibitor screen
identified the PP2A family of phosphatases as important regula-
tors of DAF-16 nuclear translocation (S.P. and H.A.T., unpub-
lished data). Second, the PP2A holoenzyme is comprised of
a catalytic, a structural, and a regulatory subunit (Janssens
et al., 2008), and RNAi of the catalytic and structural subunits
of PP2A resulted in lethality (data not shown).
daf-2(e1370) carries a mutation in the insulin receptor tyrosine
kinase domain that results in a ts phenotype for dauer formation
(Kimura et al., 1997). daf-2(e1370)worms arrest as 100% dauers
at 25C, whereas at 15C they have a normal reproductive cycle
Table 1. Epistasis Analysis of Dauer Formation Using Different IIS Pathway Mutants Grown on RNAi Clones
Percent Dauer ± Standard Deviation (n)
Strains Vector RNAi daf-18 RNAi pptr-1 RNAi
daf-2(e1368)a 69.2% ± 9.4% (202) 0% (295) 3.8% ± 4.4% (257)
daf-2(e1370)b 17.2% ± 5.9% (517) 0.2% ± 0.3% (397) 9.6% ± 7.3% (460)
daf-2(e1370);daf-3(mgDf90) 94.5% ± 0.8% (589) 40.4% ± 14.0% (308) 42.7% ± 14.6% (329)
pdk-1(sa680)a 95.6% ± 1.0% (490) 80.8%c (52) 9.5% ± 0.3% (180)
daf-2(e1370) 73.0% ± 0.2% (525) 3.5% ± 1.7% (279) 4.1% ± 3.8% (344)
daf-2(e1370);akt-1(ok525)d 94.8% ± 3.1% (237) 1.0% ± 0.3% (386) 96.0% ± 1.7% (186)
daf-2(e1370);akt-2(ok393) 36.8% ± 3.8% (336) 5.0% ± 1.1% (610) 10.8% ± 4.3% (583)
daf-2(e1370) 79.1% ± 5.4% (601) 0.7% ± 1.0% (405) 27.2% ± 14.8% (536)
daf-2(e1370);sgk-1(ok538) 65.4% ± 4.9% (338)e 0.3% ± 0.4% (303) 0% (364)
All strains were maintained at 15C and assays performed at 20C unless otherwise indicated. Also, dauer formation of all strains was scored after
3.5–4 days unless otherwise indicated. Data shown are representative of one experiment.
a The experiment was performed at 25C.
bDauers were scored after 5 days.
c In most experiments, the pdk-1(sa680) worms failed to hatch on daf-18 RNAi. This number represents 20% of the eggs picked for this assay.
dDauers were scored after 7–8 days. For daf-2(e1370);akt-1(ok525) worms on vector or pptr-1 RNAi, all of the nondauers were either partial dauers or
dauer-like. They did not develop into adults even after 2 weeks.
eDauers were scored after 7–8 days. The daf-2(e1370);sgk-1(ok538) strain shows a gro phenotype, and worms remain at the L1/L2 stage for 6–7 days
at 20C.(Riddle et al., 1997). At an intermediate temperature of 20C,
a significant percentage of daf-2(e1370) worms form dauers.
Therefore, at this temperature, one can useRNAi to easily assess
the contribution of any gene inmodulating daf-2 dauer formation.
For the screen, daf-2(e1370) mutants were grown on RNAi-
expressing bacteria for two generations, and eggs were picked
onto three plates for each RNAi clone (Figure 1B). The plates
were incubated at 20C and scored 3.5–4 days later for the pres-
ence of dauers and nondauers. Since DAF-18 is the only known
phosphatase that negatively regulates the IIS in C. elegans, we
used daf-18 RNAi as a positive control in all of our experiments.
From a total of 63 RNAi clones (57 phosphatases and six regula-
tory subunits), we identified two phosphatases that dramatically
decreased daf-2(e1370) dauer formation to a level similar to
daf-18 RNAi (Figure 1C).
Our top candidate, fem-2 (T19C3.4), functions in C. elegans
sex determination (Kimble et al., 1984; Pilgrim et al., 1995).
However, further analysis with an additional daf-2 allele, daf-
2(e1368), revealed that fem-2 RNAi suppresses dauer formation
in an allele-specific manner. fem-2 RNAi suppressed dauer
formation of daf-2(e1370) but not daf-2(e1368) (data not shown),
and therefore we focused on the next top candidate.
pptr-1 (W08G11.4), the next candidate, is a member of the B56
family of genes encoding regulatory subunits of the PP2A protein
phosphataseholoenzyme.TheC.elegansgenomecontainsseven
known PP2A regulatory subunit genes (pptr-1 and pptr-2, B56
family; sur-6, B55 family; F47B8.3, C06G1.5, rsa-1, and T22D1.5,
B72 family; currently F47B8.3 is not annotated as a PP2A regula-
tory subunit according to WormBase Release WS194). To deter-
mine the specificity of pptr-1 in regulating dauer formation, we
retested the six PP2A regulatory subunits included in the screen
for their ability to regulatedauer formation indaf-2(e1370)mutants.
Knockdown efficiency of eachRNAi clonewas verified byRTPCR
(TableS1Aavailableonline).Asshown inFigure1DandTablesS1Aand S1B, only pptr-1RNAi suppressed daf-2(e1370) dauer forma-
tion comparable to daf-18 RNAi.
We next analyzed the effect of pptr-1 RNAi on dauer formation
of daf-2(e1368). pptr-1 RNAi significantly suppressed the dauer
formation of daf-2(e1368) (69.2% ± 9.4% on vector RNAi versus
3.8% ± 4.4% on pptr-1 RNAi; Table 1 and Table S2). Therefore,
the effect of pptr-1 RNAi on daf-2 mutants is not allele specific.
Together, these results indicate that pptr-1 may function down-
stream of daf-2. In addition, pptr-1 is the only PP2A regulatory
subunit to affect daf-2 dauer formation.
pptr-1 Regulates Dauer Formation through
the IIS Pathway
To further investigate the role of pptr-1 in dauer formation,
we performed genetic epistasis analysis. In addition to the
C. elegans IIS pathway, a second parallel TGF-b pathway also
regulates dauer formation (Patterson and Padgett, 2000;
Savage-Dunn, 2005). In this pathway, loss-of-function mutations
in daf-7 (TGF-b ligand), daf-1, and daf-4 (receptors) or daf-14 and
daf-8 (R-Smads) lead to constitutive dauer formation; loss-of-
function mutations in daf-3 (Co-Smad) or daf-5 (Sno/Ski)
suppress these phenotypes (da Graca et al., 2004; Gunther
et al., 2000; Inoue and Thomas, 2000; Patterson et al., 1997;
Ren et al., 1996). However, mutations in daf-3 do not suppress
daf-2(e1370) dauer formation (Vowels and Thomas, 1992). We
generated a daf-2(e1370);daf-3(mgDf90) double mutant, which
bears a null mutation in daf-3 (Patterson et al., 1997) and
essentially removes the input from the TGF-b pathway for dauer
formation. In this strain, the dauer formation of daf-2(e1370);
daf-3(mgDf90) worms was suppressed by pptr-1 RNAi (94.5% ±
0.8% dauers on vector RNAi to 42.7% ± 14.6% dauers on pptr-1
RNAi; Table 1 and Table S2). These data suggest that pptr-1
controls dauer formation specifically through the IIS pathway
and not the TGF-b pathway.Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc. 941
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Figure 2. pptr-1 Regulates Life Span, Thermotolerance and Fat Storage through the IIS Pathway
Data shown are from one representative experiment.
(A) pptr-1 RNAi significantly reduces the life span of daf-2(e1370) mutants similar to daf-18 RNAi. Mean life span [days ± SD (n)] of daf-2(e1370) is as follows:
on vector RNAi, 33.9 ± 0.7 days (n = 77); on pptr-1 RNAi, 27.7 ± 0.9 days (n = 63), p < 0.0001; and on daf-18 RNAi, 20.4 ± 0.6 days (n = 40), p < 0.0001.
(B) pptr-1 RNAi does not affect the life span of wild-type worms. Mean life span [days ± SD (n)] of wild-type worms is as follows: on vector RNAi, 22.8 ± 0.4 days
(n = 61); and on pptr-1 RNAi, 21.9 ± 0.5 days (n = 49). daf-18 RNAi reduces mean life span of wild-type worms to 18.6 ± 0.3 days (n = 48), p < 0.0001.
(C) The thermotolerance of daf-2(e1370) worms is reduced by pptr-1 as well as daf-18 RNAi; mean survival [hours ± SD (n)] of daf-2(e1370) worms at 37C
on vector RNAi was 15.2 ± 0.7 hr (n = 34), whereas on pptr-1 RNAi the survival was 13.8 ± 0.5 hr (p < 0.006) (n = 36) and 10.3 ± 0.7 hr (p < 0.0001) (n = 29)
on daf-18 RNAi. pptr-1 RNAi did not affect the thermotolerance of wild-type worms (mean survival was 9.8 ± 0.4 hr on vector RNAi [n = 32], 9.3 ± 0.3 hr on
pptr-1 RNAi [n = 35] and 9.7 ± 0.4 hr on daf-18 RNAi [n = 32]).
(D) Sudan black staining showing that pptr-1RNAi reduces the increased fat storage of daf- 2(e1370)worms, similar to daf-18RNAi, but has no effect onwild-type
fat storage. Arrows indicate the pharynx. A representative picture from one of three independent experiments (n = 30) is shown.pptr-1 Affects Longevity, Metabolism, and Stress
Response Downstream of the IIS Receptor
In addition to dauer formation, the C. elegans IIS pathway also
regulates life span, fat storage, and stress resistance (Antebi,
2007; Kenyon, 2005; Wolff and Dillin, 2006). Since pptr-1 regu-
lates dauer formation specifically via the IIS pathway, we next
determined whether this gene could also affect these other
important phenotypes.
Mutations in daf-2 result in life span extension (Kenyon et al.,
1993) that is suppressed by loss-of-function mutations in daf-
18 (Dorman et al., 1995; Larsen et al., 1995). To investigate
whether pptr-1 can regulate life span similar to daf-18, we
determined whether knockdown of pptr-1 by RNAi could affect
daf-2(e1370) life span. We grew wild-type and daf-2(e1370)942 Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc.worms on vector, daf-18, and pptr-1 RNAi and measured life
span (Figure 2A). Similar to daf-18 RNAi, knockdown of pptr-1
resulted in a significant reduction in daf-2(e1370) life span
(mean life span of daf-2(e1370) on vector RNAi is 33.9 ±
0.7 days, on pptr-1 RNAi is 27.7 ± 0.9 days, and on daf-18
RNAi is 20.4 ± 0.6 days, p < 0.0001; Figure 2A and Table S3A).
In contrast, life span of wild-type worms was unaffected by
pptr-1 RNAi (mean life span of wild-type worms is 22.8 ±
0.4 days on vector RNAi, 21.9 ± 0.5 days on pptr-1 RNAi, and
18.6 ± 0.3 days on daf-18 RNAi; Figure 2B and Table S3A).
Thus, pptr-1 affects life span in addition to dauer formation.
Life span extension correlates well with increased stress resis-
tance (Lithgow and Walker, 2002; Oh et al., 2005). For example,
daf-2(e1370) mutants are not only long-lived but are also
extremely resistant to various stresses such as heat and
oxidative stress (Honda and Honda, 1999; Lithgow et al., 1995;
Munoz and Riddle, 2003). Therefore, we next analyzed the effect
of pptr-1 RNAi on the thermotolerance of daf-2(e1370) mutants.
As anticipated, pptr-1 RNAi significantly reduced the thermotol-
erance of daf-2(e1370) mutants. [On vector RNAi, daf-2(e1370)
had a mean survival of 15.2 ± 0.7 hr, whereas on pptr-1 RNAi
survival was 13.8 ± 0.5 hr (p < 0.006). pptr-1 RNAi did not affect
the thermotolerance of wild-type worms; mean thermotolerance
was 9.8 ± 0.4 hr on vector RNAi, versus 9.3 ± 0.3 hr on pptr-1
RNAi; Figure 2C and Table S4.]
In addition to enhanced life span and stress resistance, daf-2
mutants have increased fat storage (Ashrafi et al., 2003; Kimura
et al., 1997). We next asked whether pptr-1 could also affect fat
storage in wild-type and daf-2(e1370) worms by using Sudan
black staining. Consistent with our life span and stress resistance
results, pptr-1 RNAi suppressed the increased fat storage of
daf-2(e1370) without affecting wild-type fat storage (Figure 2D).
Finally, daf-2 mutants have a slow growth phenotype (Gems
et al., 1998; Jensenet al., 2007) that is suppressedby knockdown
of daf-16 by RNAi (Table S5). Similar to daf-16 RNAi and daf-18
RNAi, pptr-1 RNAi suppresses this slow growth phenotype.
Together, these experiments suggest that pptr-1 regulates
multiplephenotypesassociatedwith the IISpathway inC.elegans.
pptr-1 Functions at the Level of akt-1
Signals from DAF-2 are transduced to the PI 3-kinase AGE-1 to
activate the downstream serine/threonine kinase PDK-1. PDK-1
activates three downstream serine/threonine kinases, AKT-1,
AKT-2, and SGK-1 (Antebi, 2007; Kenyon, 2005; Wolff and Dillin,
2006). These kinases together regulate the transcription factor
DAF-16 by direct phosphorylation (Hertweck et al., 2004). Muta-
tions in daf-16 suppress the enhanced dauer formation of pdk-1
(Paradis et al., 1999) or akt-1/akt-2 mutants (Oh et al., 2005;
Paradis and Ruvkun, 1998). Thus far, our analysis suggests
that pptr-1 functions in the IIS pathway. We sought to identify
the potential target of pptr-1 by performing genetic epistasis
experiments on components of the IIS pathway.
First we analyzed the effect of pptr-1 RNAi on dauer formation
of a pdk-1 mutant. Dauer formation of pdk-1(sa680) was sup-
pressed by pptr-1 RNAi (95.6% ± 1.0% dauers on vector RNAi
versus 9.5% ± 0.3% dauers on pptr-1 RNAi, Table 1 and Table
S2). In contrast, daf-18 RNAi had no effect on pdk-1(sa680) da-
uer formation (Table 1 and Table S2). Therefore, these results
place pptr-1 downstream of pdk-1 and are consistent with the
current understanding that daf-18 acts upstream of pdk-1.
Next, to investigate whether pptr-1 acts at the level of akt-1,
akt-2, or sgk-1, we first analyzed dauer formation in akt-
1(ok525), akt-2(ok393), and sgk-1(ok538) single mutants and
the akt-1(ok525);akt-2(ok393) double mutant. While akt-
1(ok525), akt-2(ok393), and sgk-1(ok538) single mutants do not
arrest as dauers at either 20C or 25C, the akt-1(ok525);
akt-2(ok393) double mutant forms 100% dauers at all tempera-
tures (Oh et al., 2005). To circumvent this problem, we generated
double mutants of daf-2(e1370);akt-1(ok525), daf-2(e1370);akt-
2(ok393), and daf-2(e1370);sgk-1(ok538) and tested these strains
for dauer formation on vector, daf-18, and pptr-1 RNAi. We
reasoned that in a daf-2 mutant background, the akt-1, akt-2,and sgk-1 mutants would exhibit temperature-induced dauer
formation. Indeed, all three doublemutants were able to form da-
uers at 20C (Table 1 and Table S2—see panel for vector RNAi).
Importantly, pptr-1 RNAi significantly suppressed dauer forma-
tion indaf-2(e1370);akt-2(ok393) (36.8%± 3.8%dauers on vector
RNAi versus 10.8% ± 4.3% on pptr-1 RNAi; Table 1 and Table
S2). In addition, pptr-1 RNAi suppressed dauer formation of
daf-2(e1370);sgk-1(ok538) worms (65.4% ± 4.9% dauers on
vector RNAi versus 0% on pptr-1 RNAi, Table 1 and Table S2).
In contrast, pptr-1 RNAi did not affect dauer formation of
daf-2(e1370);akt-1(ok525) mutants (vector RNAi is 94.8% ± 3.1%
versus 96.0% ± 1.7% on pptr-1 RNAi; Table 1 and Table S2).
However, daf-18 RNAi can suppress daf-2(e1370);akt-1(ok525)
dauer formation (reduced to 10.5% ± 0.8%; Table 1). These
observations genetically place pptr-1 at the level or downstream
of akt-1 in the IIS pathway.
PPTR-1 and AKT-1 Are Expressed in the Same Tissues
Since pptr-1 and akt-1 genetically interact, we wanted to inves-
tigate whether they have a common expression pattern. We
generated or obtained akt-1::gfp, akt-2::gfp, sgk-1::gfp trans-
genic worms, and we tagged pptr-1 withmCherry and a minimal
flag tag to generate pptr-1::mCherry-flag transgenic worms
(henceforth referred to as pptr-1::mC-flag; Experimental Proce-
dures; GFP/mC-FLAG refers to protein and gfp/mC-flag stands
for transgene). We made double transgenic worms by crossing
pptr-1::mC-flag worms to each of the above-mentioned GFP
lines. Similar to published data, we observed AKT-1::GFP
predominantly in the pharynx, several head neurons, the nerve
ring, spermathecae, and vulva (Paradis and Ruvkun, 1998);
AKT-2::GFP in the pharynx (predominantly in the anterior region),
somatic muscles, vulva muscles, and spermathecae (Paradis
and Ruvkun, 1998); and SGK-1::GFP in amphid neurons, intes-
tine, and some tail neurons (Hertweck et al., 2004) (Figures 3A–
3C, middle panel, and Figure S1). PPTR-1::mC-FLAG was also
observed in the pharynx, head neurons, nerve ring, spermathe-
cae, and vulva (Figures 3A–3C, left panel, and Figure S1). To
observe the subcellular localization of PPTR-1, we stained
pptr-1::mC-flag worms with DAPI (Experimental Procedures).
We found that PPTR-1 is predominantly cytosolic with little
DAPI overlap (Figure S2 andMovies S1–S8). As shown in Figures
3A–3C (Merge) as well as in the confocal movies (Movies S1–S8),
there is remarkable overlap between the expression patterns of
PPTR-1 and AKT-1. We also observed partial overlap between
AKT-2::GFP and PPTR-1::mC-FLAG, predominantly in the
pharynx (Figure 3B, Merge; Movies S1–S8). SGK-1 and PPTR-1
are expressed in different tissues, and we do not see any signif-
icant overlap (Figure 3C, Merge; Movies S1–S8).
PPTR-1 Regulates AKT-1 Phosphorylation
Given the genetic epistasis as well as the overlapping expression
patterns, we next determined whether PPTR-1 directly interacts
with AKT-1 by coimmunoprecipitation (co-IP) in C. elegans. For
all biochemical experiments, we used the PD4251 strain as
a control. This strain contains Pmyo-3::gfp with a mitochondrial
localization signal and Pmyo-3::lacZ-gfp with a nuclear localiza-
tion signal (Fire et al., 1998). This strain will be referred to as
myo-3::gfp. We prepared lysates from mixed-stage akt-1::gfp;Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc. 943
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Figure 3. PPTR-1 Colocalizes with AKT-1
akt-1::gfp;pptr-1::mC-flag, akt-2::gfp;pptr-1::mC-
flag, and sgk-1::gfp;pptr-1::mC-flag transgenic
worms were mounted and visualized by fluores-
cence microscopy with Rhodamine (mCherry)
and FITC (GFP) filters. PPTR-1 expression is
observed mainly in the pharynx, vulva, and sper-
matheca ([A]–[C], mCherry).
(A) Expression of PPTR-1::mC-FLAG (mCherry)
and AKT-1::GFP (GFP) in a akt-1::gfp; pptr-
1::mC-flag strain. Expression of PPTR-1::mC-
FLAG overlaps with AKT-1::GFP (Merge).
(B) PPTR-1::mC-FLAG and AKT-2::GFP colocalize
in some tissues in a akt-2::gfp; pptr-1::mC-flag
strain (Merge).
(C) SGK-1::GFP and PPTR-1::mC-FLAG do not
colocalize in sgk-1::gfp;pptr-1::mC-flag transgenic
worms (Merge).
Arrows indicate the following tissues: p, pharynx;
v, vulva; s, spermatheca; i, intestine.pptr-1::mC-flag andmyo-3::gfp; pptr-1::mcherry-flag transgenic
worms. After immunoprecipitation with either anti-FLAG or
anti-GFP antibody, we found that PPTR-1 specifically interacts
with AKT-1 and not with MYO-3::GFP (Figure 4A; Experimental
Procedures). We also performed co-IP experiments to investi-
gate whether PPTR-1 and AKT-2 interact since we observed
partial overlap in expression pattern of these proteins. We find
that PPTR-1 does not interact with AKT-2 (Figure S3). Our epis-
tasis analyses show no genetic interaction between pptr-1 and
sgk-1. Moreover, we observe no overlap in the expression
pattern of these two proteins with confocal microscopy (Movies
S1–S8). However, we find that PPTR-1::mC-FLAG and SGK-
1::GFP can interact in our co-IP experiments (Figure S3). We do
not believe this biochemical interaction to have a measurable
functional output and did not pursue it further.
In mammals, Akt is activated by PDK phosphorylation at Thr
308 and PDK-2/TORC-2 protein complex at Ser 473 (Brazil
and Hemmings, 2001; Sarbassov et al., 2005). In C. elegans
AKT-1, these sites correspond to Thr 350 and Ser 517, respec-
tively. We generated affinity-purified phospho-specific anti-
bodies (21st Century BioChemicals, Malboro, MA; Experimental944 Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc.Procedures) against both sites to further
investigate the role of PPTR-1 on AKT-1
phosphorylation. After immunoprecipita-
tion with anti-GFP antibody from either
akt-1::gfp or akt-1::gfp;pptr-1::mC-flag
strain, we compared the phosphorylation
status at these two sites. We find that
overexpression of PPTR-1 can dramati-
cally decrease the phosphorylation of
the T350 site while having a marginal
effect on the Ser 517 site (Figure 4B).
As a control experiment, we treated
the immunoprecipitated AKT-1::GFP
samples with lambda phosphatase and
observed loss of the Thr and Ser phos-
phorylation, showing the specificity ofthe phospho-AKT antibodies (Figure S4A). Thus, in C. elegans,
PPTR-1 functions by directly regulating the dephosphorylation
of AKT-1 primarily at the Thr 350 (mammalian Thr 308) site.
Mammalian PPTR-1 Homolog Regulates AKT-1
Phosphorylation
Given the evolutionary conservation of the C. elegans IIS
pathway, we next determined whether this mechanism of
AKT-1 dephosphorylation mediated by PPTR-1 is also
conserved in mammals. The mammalian B56 family of PP2A
regulatory subunits has eight members encoded by five genes
that express in different tissues (Eichhorn et al., 2008). We
used 3T3-L1 adipocytes to perform these studies since in this
system there is a well-characterized insulin signaling pathway
that is responsive to changes in insulin levels (Ugi et al., 2004;
Watson et al., 2004). We first compared microarray data from
the expression profiles of fibroblasts to differentiated 3T3-L1
adipocytes (Powelka et al., 2006) to determine which B56
members were expressed in the adipocytes. We identified two
genes, PPP2R5A (B56a) and PPP2R5B (B56b), as the top candi-
dates. We knocked down either one or both these regulatory
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Figure 4. PPTR-1 Interacts with and Modulates AKT-1 Phosphorylation
Data shown are from one representative experiment.
(A) PPTR-1 directly interacts with AKT-1 in C. elegans. AKT-1::GFP and MYO-3::GFP were immunoprecipated (IP) with anti-GFP antibody and analyzed by
western blotting (WB) with anti-Ds-Red or anti-GFP antibodies. In addition, PPTR-1::mC-FLAG was immunoprecipitated with anti-FLAG antibody and analyzed
by WB with anti-Ds-Red or anti-GFP antibodies. Lysates were used for WB analysis.
(B) PPTR-1 overexpression reduces AKT-1 phosphorylation in C. elegans. AKT-1::GFP and MYO-3::GFP were immunoprecipitated from akt-1::gfp, akt-
1::gfp;pptr-1::mC-flag and myo-3::gfp;pptr-1::mC-flag followed by western blotting with pThr 350 or pSer 517 antibodies (upper panels). Total lysates were
analyzed by western blotting (lower panels). Quantification of changes in AKT-1::GFP phosphorylation upon PPTR-1 overexpression is shown below each lane.
(C) Knockdown of the mammalian B56b regulatory subunit by siRNA in 3T3-L1 adipocytes increases insulin-stimulated AKT phosphorylation at Thr 308. The 3T3-
L1 adipocytes were transfected with scrambled (Scr), PP2Aca/b, B56a, B56 b, or B56a/b siRNA. These cells were then treated with increasing concentrations of
insulin, and the phosphorylation status of Akt was analyzed by western blotting with pThr 308 (left) and pSer 473 (middle) antibodies. Total Akt antibody was used
as a loading control (right). Quantification of fold changes in Akt phosphorylation is shown below each lane.subunits by designing Smartpool siRNAs (Dharmacon, Lafay-
ette, CO) and verified the silencing by quantitative RT-PCR
(Figure S3B). Serum-starved siRNA-treated 3T3-L1 adipocytes
were then stimulated with increasing concentrations of insulin.
The cells were lysed and the proteins analyzed by Western blot-
ting with mammalian Akt phospho-specific antibodies (Experi-
mental Procedures). Knockdown of B56b results in a dramatic
increase in phosphorylation at the Thr 308 site of Akt with rela-
tively less changes in Ser 473 phosphorylation (Figure 4C).
However, silencing of B56a had no effect on the phosphorylation
status of Akt at either site. We observed that siRNA against both
the PP2A catalytic subunits (PP2Aca/b) results in increasedphosphorylation at Thr 308 but not at Ser 473. Together, our
data suggest that PPTR-1/B56b regulatory subunits function to
modulate AKT-1 phosphorylation in a conserved manner across
phylogeny.
PPTR-1 Positively Regulates DAF-16 Nuclear
Localization
We next determined the consequences of modulating PPTR-1
dosage on the IIS pathway. InC. elegans, one of themajor targets
of AKT-1 is the forkhead transcription factor, DAF-16. Active
signaling through the IIS pathway results in the phosphorylation
of DAF-16 by AKT-1, AKT-2, and SGK-1, leading to its nuclearCell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc. 945
exclusion (Antebi, 2007; Kenyon, 2005; Wolff and Dillin, 2006).
However, under low signaling conditions, DAF-16 translocates
into the nucleus, where it can directly bind and activate/repress
the transcription of target genes involved in dauer formation,
life span, stress resistance, and fat storage (Oh et al., 2006). We
askedwhetherpptr-1 regulates IISpathway-specific phenotypes
by modulating DAF-16 function. Since we observed reduced
phosphorylation of AKT-1 upon overexpression of PPTR-1, we
first looked at the effect of PPTR-1 overexpression on DAF-16
nuclear localization (Henderson and Johnson, 2001; Lee et al.,
2001; Lin et al., 2001). We generated a daf-16::gfp;pptr-1::mC-
flag strain and then compared the DAF-16 nuclear localization in
thesewormswith a daf-16::gfp strain (Figure 5A and Figure S5A).
We categorized DAF-16::GFP localization as completely cyto-
solic, mostly cytosolic, mostly nuclear, or completely nuclear.
We find that DAF-16::GFP nuclear localization is enhanced
when PPTR-1 is overexpressed (Figure 5A and Figure S5A). To
determine the specificity of this response, we used mCherry
RNAi to effectively knock down mCherry expression in pptr-
1::mC-flag, thereby reducing the expression of pptr-1 transgene
(data not shown). Our results show that the enhanced nuclear
localization upon PPTR-1 overexpression is suppressed when
pptr-1::mC-flag;daf-16::gfp worms are grown on mCherry RNAi
(Figure 5A and Figure S5A) and thatmCherry RNAi has little effect
on DAF-16 localization in daf-16::gfp worms. These experiments
suggest that increased dosage of pptr-1 affects DAF-16 nuclear
localization. Consistent with its role in the C. elegans IIS pathway,
we find that overexpression of pptr-1 significantly increases the
life span of wild-type worms but does not further enhance the
life span daf-2(e1370)worms (Figure 5B and Table S3B; mean life
span of the wild-type is 23.9 ± 0.3 days, pptr-1::mC-flag is 30.1 ±
0.5 days, p < 0.0001, and the unc-119(+); unc-119(ed3) control
strain is 22.6 ± 0.3 days).
As a corollary to this experiment, we next looked at the
effect of pptr-1RNAi on DAF-16 nuclear localization. For this,
we generated a strain with a daf-2(e1370);daf-16::gfp strain. At
the permissive temperature of 15C, DAF-16::GFP is excluded
from the nucleus in the daf-2(e1370);daf-16::gfp strain. However,
at the nonpermissive temperature of 25C, progressive nuclear
localization of DAF-16::GFP is observed. We grew daf-2(e1370);
daf-16::gfp worms on vector, pptr-1, or daf-18 RNAi and
measured the extent of nuclear localization at 25C. We find
that pptr-1 RNAi significantly reduced DAF-16 nuclear localiza-
tion, similar to the effect of daf-18 RNAi (Figure 5C and
Figure S5B). Together, these experiments suggest that changes
in PPTR-1 levels affect the activity of AKT-1 and, as a result,
modulate DAF-16 subcellular localization.
PPTR-1 Positively Regulates DAF-16 Target Genes
DAF-16 regulates the transcription of many downstream genes
such as sod-3, hsp-12.6, sip-1, and mtl-1 (Furuyama et al.,
2000; Lee et al., 2003; McElwee et al., 2003; Murphy et al.,
2003; Oh et al., 2006). We next tested the effects of pptr-1
RNAi on these DAF-16 transcriptional targets. We first tested
sod-3, which has been shown to be a direct target of DAF-16
by chromatin immunoprecipitation (Oh et al., 2006), and its
expression changes in response to modulation of the IIS
pathway (Furuyama et al., 2000; Libina et al., 2003; Murphy946 Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc.et al., 2003). We grew a daf-2(e1370);Psod-3::gfp(muIs84) strain
on vector, daf-18, or pptr-1 RNAi to look at the effect on GFP
expression. Similar to worms grown on daf-18 RNAi, pptr-1
RNAi reduces expression of GFP (Figure 5D and Figure S5C).
Therefore, modulation in the levels of pptr-1 can affect the
expression of direct DAF-16 target genes.
We further analyzed the expression of known DAF-16 target
genes by quantitative RT-PCR in a daf-2(e1370) mutant back-
ground. As a control, we analyzed whether each of these target
genes expressed in a daf-16-dependentmanner as previously re-
ported (McElwee et al., 2003;Murphy et al., 2003; Oh et al., 2006).
As shown in Figure 5E and Figure S5D, daf-16 RNAi dramatically
suppressed the expression levels of these genes. Next, we tested
the effects of either pptr-1 or daf-18 RNAi on the expression of
these genes. We found that pptr-1 RNAi also suppressed the
expression of these genes to a level similar to daf-18RNAi. Taken
together, our data suggest that PPTR-1 positively regulates
DAF-16 nuclear localization and thereby its activity.
DISCUSSION
In a directed RNAi screen for Ser/Thr phosphatases in the
C. elegans IIS pathway, we identified pptr-1, a B56 regulatory
subunit of the PP2A holoenzyme. PP2A itself is a ubiquitously
expressed phosphatase that is involved in multiple cellular
processes including regulation of insulin signaling by direct
dephosphorylation of Akt (Andjelkovic et al., 1996; Resjo et al.,
2002; Ugi et al., 2004). Substrate specificity of PP2A is achieved
by its association with distinct regulatory subunits. Our studies
provide a mechanistic insight into how the C. elegans PP2A
regulatory subunit PPTR-1modulates insulin signaling by specif-
ically regulating AKT-1 phosphorylation and activity in the
context of a whole organism.
In our model (Figure 5F), PPTR-1 acts to negatively regulate
signals transduced through the IIS pathway, ultimately control-
ling the activity of the FOXO transcription factor DAF-16. Under
low signaling conditions, DAF-16 is able to translocate to the
nucleus and transactivate or repress its downstream targets. It
is well established that AKT modulates DAF-16 subcellular
localization. Thus, the activity of AKT-1, as governed by its
phosphorylation status, directly translates into the activity of
DAF-16. In this study, we show that PPTR-1 directly interacts
with AKT-1 and regulates its activity by modulating its phos-
phorylation, predominantly at the Thr 350 site. Less active
AKT-1 results in increased DAF-16 nuclear localization. Indeed,
DAF-16 is found to be more nuclear throughout the worm when
PPTR-1 is overexpressed. As a corollary, knockdown of pptr-1
by RNAi results in less nuclear DAF-16 as well as reduced
expression of DAF-16 target genes such as sod-3, hsp-12.6,
mtl-1, and sip-1. These genes are known to play a combinatorial
role in adaptation to various stresses, leading to enhanced da-
uer formation and increased life span. Consistent with the
decreased levels of these important genes, pptr-1 RNAi results
in a significant decrease in the dauer formation, life span, and
thermotolerance of daf-2(e1370) mutants. In addition, pptr-1
also regulates other DAF-16-dependent outputs of the IIS
pathway, such as fat storage. Thus, we find that normal levels
of pptr-1 are important under low insulin signaling conditions.
Strain RNAi High (%) Medium (%) Low (%) (n)
daf-2(e1370);
sod-3::gfp
vector 36.6 46.6 16.6 30
daf-18 10.0 50.0 40.0 30
pptr-1 6.6 43.3 50.0 30
Strain RNAi
Transcripts determined by Q-PCR (% of vector RNAi)
sod-3 hsp-12.6 sip-1 mtl-1
daf-2(e1370)
daf-16 7.8 10.8 24.7 0.7
daf-18 46.8 35.2 84.1 17.8
pptr-1 45.2 52.2 86.7 32.0
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Cytoplasmic
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Figure 5. PPTR-1 Regulates DAF-16 Localization and Activity
Data shown are from one representative experiment.
(A) Overexpression of PPTR-1 promotes DAF-16 nuclear translocation. On vector RNAi, DAF-16 is more enriched in the nucleus in a pptr-1::mC-flag;daf-16::gfp
strain, compared to a daf-16::gfp strain. This effect is specific to the functional transgene, as knockdown of pptr-1::mC-flag with mCherry RNAi decreases the
extent of nuclear DAF-16.
(B) Overexpression of PPTR-1 significantly increases the life span of wild-type worms. Mean life span [days ± SD (n)] of wild-type worms is 23.9 ± 0.3 days
(n = 154); of pptr-1::mC-flag is 30.1 ± 0.5 days (n = 202), p < 0.0001; and of the unc-119(+); unc-119(ed3) control strain is 22.6 ± 0.3 days (n = 145).
(C) In a daf-2(e1370);daf-16::gfp strain, DAF-16 is enriched in the nucleus on vector RNAi, whereas on pptr-1 RNAi as well as daf-18 RNAi, DAf-16 is mostly
cytosolic.
(D) pptr-1 RNAi affects DAF-16 transcriptional activity. sod-3 is one of the direct targets of DAF-16. pptr-1 RNAi reduces Psod-3::GFP expression in a
daf-2(e1370);Psod-3::gfp(muIs84) strain, similar to daf-18 RNAi.
(E) Transcript abundance of known DAF-16 target genes decrease when daf-2(e1370) worms are grown on pptr-1 RNAi, similar to daf-18 RNAi, as detected by
real-time PCR.
(F) Proposedmodel illustrating the role of PPTR-1 in the insulin/IGF-1 signaling pathway. Signals fromDAF-2 are processed by a PI3-kinase pathway that leads to
the phosphorylation and activation of downstream serine/threonine kinases such as PDK-1, AKT-1, AKT-2, and SGK-1. PPTR-1, the PP2A holoenzyme regulatory
subunit, regulates the dephosphorylation and activation status of AKT-1 at T350. This in turn affects the nuclear translocation of DAF-16 and the expression of
genes involved in life span, dauer formation, stress resistance, and fat storage.However, pptr-1 RNAi does not affect IIS pathway-associated
phenotypes in wild-type worms. There could be several reasons
for this observation. First, under normal signaling conditions,
AKT-1, AKT-2, and SGK-1 are active and negatively regulate
DAF-16. Therefore, changes in the AKT-1 activity alone brought
about by pptr-1 RNAi may not have a significant effect on
DAF-16-dependent phenotypes. Second, PPTR-1 itself may
be negatively regulated by the IIS pathway, leading to increased
AKT-1 phosphorylation. Along similar lines, in mammals, insulin
signaling can downregulate the expression and activity of thePP2A catalytic subunit (Hojlund et al., 2002; Srinivasan and
Begum, 1994; Ugi et al., 2004). Thus, under normal conditions,
further downregulation of pptr-1 by RNAi may have no effect.
We speculate that in C elegans, in response to changing envi-
ronmental cues, PPTR-1 helps to downregulate the insulin
signaling pathway to promote DAF-16 activity, enabling the
worm to either enter diapause or enhance its tolerance to stress
as adults.
In mammals, Akt controls a myriad of secondary signaling
cascades that regulate glucose transport, protein synthesis,Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc. 947
genomic stability, cell survival, and gene expression (Toker and
Yoeli-Lerner, 2006). Previous studies have implicated roles for
PP2A and PHLPP phosphatases in the negative regulation of
Akt (Kuo et al., 2008). The PP2A inhibitor Okadaic acid can
increase Akt phosphorylation predominantly at Thr 308 and
enhance glucose transport in adipocytes (Rondinone et al.,
1999). Consistent with this, our results show that siRNA knock-
down of the PP2A catalytic subunit and, more importantly, the
B56b regulatory subunit results in enhanced Akt phosphorylation
at Thr 308 in 3T3-L1 adipocytes. Thus, our study points at the
remarkable functional conservation of the B56/PPTR-1 regula-
tory subunit of PP2A in regulating AKT phosphorylation between
C. elegans and highermammals. Inworms, we also see amodest
effect on Ser 517 (equivalent to mammalian Ser 473) phosphor-
ylation by PPTR-1 overexpression. However, we do not observe
a difference in Ser 473 phosphorylation in adipocytes. This differ-
ence may be explained by the fact that in worms, we are deter-
mining the phosphorylation of AKT-1 in the context of a whole
organism. Additionally, in mammals, phosphorylation state of
one Akt site may influence the status of the other (Gao et al.,
2005; Toker and Newton, 2000). We do not see a role for the
PP2A B55 subunit (sur-6) in the C. elegans IIS pathway.
However, a recent report using cell culture has implicated the
mammalian B55 in the regulation of AKT (Kuo et al., 2008).
Dysregulation of Akt has been implicated in diseases such as
cancer and diabetes (Rondinone et al., 1999; Sasaoka et al.,
2006; Smith et al., 1999; Zdychova and Komers, 2005). In fact,
the onset of diabetes is often associated with changes in Akt
phosphorylation (Zdychova and Komers, 2005). In several
cancer models, loss-of-function mutations in the PTEN results
in hyperphosphorylated and activated Akt (Groszer et al., 2001;
Hakem and Mak, 2001; Stiles et al., 2002; Testa and Bellacosa,
2001) Our studies show that, like PTEN, PPTR-1 acts to nega-
tively regulate the insulin/IGF-1 signaling. Given the important
role of PPTR-1/B56 in modulating Akt activity, this protein may
be a potential therapeutic target for the treatment of diabetes
as well as cancer.
EXPERIMENTAL PROCEDURES
Strains
All strains were maintained at 15C via standard C. elegans techniques (Stier-
nagle, 2006). Double mutants were made by standard genetic methods, while
transgenic worms were made by microparticle bombardment as described in
the Supplemental Experimental Procedures. For all RNAi assays, the worms
were grown for at least two full generations on the RNAi bacteria. Preparation
of RNAi plates is described in the Supplemental Experimental Procedures.
C. elegans Assays
C. elegans assays were modified from previously publishedmethods (Hender-
son and Johnson, 2001; Kimura et al., 1997; Libina et al., 2003; Oh et al., 2006;
Oh et al., 2005). For detailed description of these assays, see the Supple-
mental Experimental Procedures.
C. elegans Immunoprecipitation and Western Blotting
Transgenic worms were grown in three 100 mm plates seeded with OP50
bacteria at 20C. Worms were harvested by washing with M9 buffer and pellet
collected by centrifugation. The pellet was resuspended in 250 ml lysis buffer
(20 mM Tris-Cl, 137 mM NaCl, 10% glycerol, 1% Triton X-100, 25 mM b-glyc-
erophosphate, Protease inhibitor cocktail [Roche Biochemicals, Indianapolis,
IN] [pH 7.4]). The worms were sonicated with Bioruptor (Diagenode, Sparta,948 Cell 136, 939–951, March 6, 2009 ª2009 Elsevier Inc.NJ) using maximum power output (1 min sonication, 2 min off—repeated ten
times). The lysate was cleared by centrifugation, and protein content was esti-
mated by the Bradford method. Lysate equivalent to 1.5 mg total protein was
precleared with 50 ml of protein-G agarose beads, fast flow (Upstate, Billerica,
MA) and then immunoprecipitated overnight at 4Cwith either anti-GFPmono-
clonal antibody (Sigma, St. Louis, MO) or anti-FLAG M2 gel (Sigma). The
following morning, 50 ml protein-G agarose beads, fast flow were added to
the GFP immunoprecipitation (IP) to capture the immune complex. The
agarose beads were then washed five times with lysis buffer. After this step,
the beads were boiled in Laemelli’s buffer.
For Western blot analysis, immunoprecipitated protein samples was
resolved on a 10% SDS-PAGE and transferred to nitrocellulose membranes.
Membranes were blocked in TBST (Tris-Buffered Saline containing 0.05%
Tween 20 [ph 7.4]) containing 5% nonfat milk at room temperature for 1 hr.
Membranes were then washed with TBST and incubated overnight with
1:1000 dilutions of antibodies in TBST containing 5% nonfat milk at 4C.
Membranes were washed three times with TBST and then incubated with
TBST containing 5% nonfat milk containing a 1:10,000 dilution of the
secondary antibody. Antibodies used for western were the following:
Living Color DsRed antibody (Clontech, Mountain View, CA; catalog
number 632496)
Living Color Rabbit polyclonal GFP antibody (BD Biosciences, San Jose,
CA; catalog number 632460)
Monoclonal mAb 3e6 GFP antibody (Invitrogen, Carlsbad, CA; catalog
number A11120)
Anti-FLAG M2 Affinity Gel (Sigma; catalog number A2220).
C. elegans Phospho-AKT Western Blotting
Transgenic worms were grown at 20C in 3–4 large (100 mm) plates seeded
with OP50. Worms were collected by washing with 13 PBS and the pellet
was then immediately frozen in dry ice. Around 500 ml lysis buffer, supple-
mented by Sigma Phosphatase inhibitor cocktails I and II (503) and Protease
inhibitor cocktail (Roche Biochemicals) was added to the pellet and sonicated
with aMisonix (3000) sonicator (Misonix, Farmingdale, NY; power output set at
4, three pulses of 10 s each with 1 min interval between pulses). The lysates
were clarified by centrifugation at 13,000 rpm for 10min at 4C, and the protein
content was estimated by Quick Bradford (Pierce). About 3.5 mg of anti-GFP
monoclonal antibody (3E6, Invitrogen USA) was used for each IP from lysates
containing 1.7 mg protein in a volume of 1 ml. IPs were performed overnight at
4C and antibody-protein complexes were captured with 50 ml of protein-G
agarose beads, fast flow (Upstate) for 2 hr at 4C. The pellets were washed
three times with lysis buffer supplemented by protease and phosphatase
inhibitors and boiled in Laemelli’s buffer. The IP samples were then resolved
on a 10% SDS-PAGE, western blotted, and analyzed with phospho-specific
antibodies (Supplemental Experimental Procedures).Mammalian Cell Culture and Phospho-Akt Western Blotting
3T3-L1 adipocytes were cultured and differentiated as previously described
(Tesz et al., 2007). For siRNA transfections, cells from 4 days after induction
of adipocyte differentiation were used as previously described (Tang et al.,
2006). Cells were stimulated with increasing concentrations of insulin, and
isolated proteins were analyzed by western blotting. The detailed procedure
is described in the Supplemental Experimental Procedures.RNA Isolation and Real-Time PCR
Total RNA was isolated with Trizol (Invitrogen), and real-time PCR was
performed according to the manufacturer’s instructions (Applied Biosystems,
Foster City, CA) as detailed in the Supplemental Experimental Procedures.SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, five
figures, seven tables, and eightmovies and can be foundwith this article online
at http://www.cell.com/supplemental/S0092-8674(09)00073-7.
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